Integer Holdings (NYSE:ITGR) earnings for the second quarter fell below Wall Street estimates. The Frisco, Texas-based medical device contract manufacturer posted profits of $23 million or 70¢ per share, on sales of $314 million for the three months ended June 29. Earnings per share were 18¢ behind the average estimate on Wall Street, where analysts were looking […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
Valeritas touts use of V-Go device compared to insulin injections
Valeritas (NSDQ:VLRX) touted data today from an analysis showing that insulin-dependent people with Type 2 diabetes benefited from using the company’s wearable V-Go insulin delivery device. The study featured people who previously treated their diabetes using multiple daily injections of insulin. After switching to the V-Go device under the care of advanced practitioners, participants were monitored […]
BD shares down despite Street-beating FY2018 Q3
Shares in Becton Dickinson & Co. (NYSE:BDX) have fallen today despite the medical device maker beating expectations on Wall Street with its fiscal year 2018 third quarter earnings results. The Franklin Lakes, N.J.-based company posted profits of $594 million, or 2.03¢ per share, on sales of $4.3 billion for the three months ended June 30, seeing […]
VisCardia heart failure implant study underway in Ukraine
Novel heart failure device developer VisCardia, Inc. (Portland, Ore.) announced the first implant of the VisONE system for heart failure and the launch of the system’s heart failure pilot study in Ukraine. The VisONE implantable system delivers asymptomatic diaphragmatic stimulation (ADS) therapy to improve cardiac function. A surgeon laparoscopically implants a medical device equipped with electrodes to deliver electrical […]
Masimo Q2 posts beat-and-raise Q2
Masimo (NSDQ:MASI) today posted second quarter earnings that beat expectations on Wall Street and raised its guidance for the remaining fiscal year. The Irvine, Calif.-based company posted profits of $43.8 million, or 79¢ per share, on sales of $211.6 million for the three months ended June 30, seeing the bottom line shrink 2.8% while sales grew […]
ConMed posts Street-beating Q2
ConMed (NSDQ:CNMD) today posted second quarter earnings that beat Wall Street expectations and lifted its sales growth guidance for the remaining year. The Utica, N.Y.-based company posted profits of $212.8 million, or 30¢ per share, on sales of $8.7 million for the three months ended June 30, for bottom-line growth of 42% on sales growth of 7.9% […]
K2M posts mixed-bag Q2
K2M (NSDQ:KTWO) today posted second quarter earnings results that beat Wall Street expectations on sales, but missed on loss-per-share consensus. The Leesburg, Va.-based company posted losses of $10.8 million, or 25¢ per share, on sales of $73.6 million for the three months ended June 30, seeing losses grow 19.2% on sales growth of 12% compared with the […]
Globus Medical whales on Wall Street’s Q2 expectations
Globus Medical (NYSE:GMED) today whaled on the consensus expecation with its second-quarter results and raised its outlook for the rest of the year. Audubon, Pa.-based Globus posted profits of $45.0 million, or 44¢ per share, on sales of $173.4 million for the three months ended June 30, for a bottom-line gain of 56.9% on sales growth […]
AtriCure posts Street-beating Q2, raises sales outlook
AtriCure (NSDQ:ATRC) today posted second quarter earnings that beat expectations on Wall Street and lifted its sales guidance for the remaining year. The Mason, Ohio-based company posted losses of $338,000, or 1¢ per share, on sales of $51.8 million for the three months ended June 30, seeing losses shrink 95.1% while sales grew 14.5% compared with […]
Dexcom beats the Street with Q2 results
Dexcom (NSDQ:DXCM) topped sales and earnings expectations on Wall Street today with its second-quarter financial results. The San Diego, Calif.-based company posted profits of $30.2 million, or 34¢ per share, on sales of $242.5 million for the three months ended June 30, representing a whopping 941% increase in profits and a 42% increase in sales compared […]
Nemaura touts data from home-use study of wearable glucose monitor
Nemaura Medical (NSDQ:NMRD) said today that it launched a study of its wearable glucose monitor in the hopes of winning regulatory approval in the U.S. The England-based company touted positive interim data from the study, focusing on the at-home use of the sugarBeat device. Get the full story at our sister site, Drug Delivery Business News.